Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling: Saikosaponin D reverses gemcitabine resistance

Intrahepatic cholangiocarcinoma (iCCA) is a highly fatal malignancy with rapidly increasing incidence and mortality worldwide. Currently, gemcitabine-based systemic chemotherapy is the main clinical therapeutic regimen; however, its efficacy is poor, and its mechanism has not been elucidated. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hui, Guo, Jiaqi, Hu, Yunxiang, Zhang, Han, Li, Xinyang, Zhang, Jian, Jin, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520481/
https://www.ncbi.nlm.nih.gov/pubmed/37489008
http://dx.doi.org/10.3724/abbs.2023040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520481/
https://www.ncbi.nlm.nih.gov/pubmed/37489008
http://dx.doi.org/10.3724/abbs.2023040

Ejemplares similares